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Health in Action
R
esearch can play a critical 
role in the response to global 
health challenges. But when 
resources are limited, guidelines are 
needed to assist decisions on deﬁ  ning 
the priorities for health research 
investments. An early attempt at the 
global level to deﬁ  ne health research 
priorities was made through the 
Commission on Health Research for 
Development in 1990 [1]. A number 
of subsequent initiatives addressed this 
problem by attempting to set priorities 
in global health research [2–4]. 
However, these approaches promoted 
funding for research predominantly 
focused upon the generation of 
new technologies, knowledge, and 
processes. Research concerned with 
implementation of already proven 
technologies and interventions was 
downplayed [5].
The persisting unacceptable 
burden of under-age-5 mortality of 
10.6 million each year [6], which 
could be reduced by up to 63% 
with existing low-cost interventions 
[7], points to the potential role 
health research could play. The 
lack of systematic prioritization of 
child research funding perpetuates 
the neglect of interest in research 
on how to implement cost-
effective interventions. Delivery of 
interventions is rarely considered a 
research priority; research on creating 
new interventions far exceeds that 
on delivering existing ones [5]. The 
Child Health and Nutrition Research 
Initiative (CHNRI) has developed 
a systematic methodology for 
setting priorities in health research 
investments that can be applied 
at global and national levels and 
for different purposes (addressing 
a disease, group of diseases, risk 
factors, etc.) [5]. The proposed major 
conceptual advance of CHNRI’s 
methodology is the recognition that 
there should be a broader deﬁ  nition 
of health research as an activity that 
is not limited to generating new 
knowledge, but also has a vision of 
implementation that should help 
to reduce present disease burden. 
The methodology also attempts to 
systematically incorporate wider 
societal values and priorities. 
This article reports on the 
ﬁ  rst experience with country-
level implementation of this new 
methodology in South Africa. It is 
estimated that nearly 100,000 children 
under 5 years of age still die each year 
in South Africa. The overall infant 
mortality rate of 59 per 1,000 live births 
has been rising over the last decade 
[8]. This rate also masks great variation 
within the country with some districts 
reporting an infant mortality rate of 
28 and others 68 per 1,000 live births 
[9]. HIV/AIDS is now the leading 
cause of under-age-5 deaths (40.3%). 
Diarrhoeal disease, lower respiratory 
tract infections, and malnutrition, 
when adjusted for HIV/AIDS 
comorbidity, are together responsible 
for 20.3% of all under-age-5 deaths 
[10]. The two aims of the study were: 
(1) to determine whether the CHNRI 
methodology was implementable for 
setting child-health care priorities at 
the national level, and (2) to identify 
“child health priorities” in South 
Africa.
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Summary Points
•  This paper aims to deﬁ  ne health 
research priorities in South Africa, 
where it is estimated that nearly 
100,000 children under 5 years of age 
still die each year.
•  The authors applied the methodology 
for setting priorities in health research 
investments recently developed by 
Child Health and Nutrition Research 
Initiative (CHNRI).
•  The predominant research priorities 
identiﬁ  ed within the existing South 
African context were health policy and 
systems research activities to generate 
new knowledge on improving delivery 
of the simplest and most cost-effective 
existing interventions.
•  Vitamin A supplementation was 
ranked ﬁ  rst, followed by hand washing, 
antibiotics for pneumonia, prevention 
of mother-to-child HIV transmission 
(PMTCT), and exclusive breast-feeding.
•  The CHNRI methodology has the 
power to discriminate among many 
competing research options using a 
simple conceptual framework.PLoS Medicine  |  www.plosmedicine.org 1294 August 2007  |  Volume 4  |  Issue 8  |  e259
Methods
Activities of the technical working 
group. The rationale for CHNRI 
methodology and its conceptual 
framework, application guidelines, 
and strategies to address the needs 
of the stakeholders have all been 
described in detail elsewhere [5,11]. 
Box 1 presents the elements of the 
methodology at a glance. In the ﬁ  rst 
step, a group of six leading South 
African technical experts in the area 
of child health formed a technical 
working group (TWG). All are involved 
in national policy development and 
have experience working in both 
rural and urban settings across South 
Africa. Four of the experts are child 
health specialists with three currently 
engaged mostly in clinical practice, 
one is a clinical child psychologist, and 
the sixth is a medical demographer. 
Only two of the six have qualiﬁ  cations 
or expertise in public health. Because 
of valid concerns that the choice 
of TWG members may signiﬁ  cantly 
affect the outcomes of the process, we 
discuss how this issue is addressed in 
the CHNRI methodology under the 
“limitations” section below.
Context was deﬁ  ned by the TWG 
in space as national (South Africa), 
in time as the next 10 years, target 
population as children below 5 years 
of age, and target disease burden 
as all cases of child deaths expected 
to occur within that period in those 
under age 5. The seven leading causes 
of death that account for more than 
90% of child deaths in South Africa 
were then identiﬁ  ed: HIV/AIDS, 
pneumonia, diarrhoea, neonatal 
causes, malnutrition, accidents and 
injuries, and congenital and genetic 
disorders. The health research 
domains in which research options 
were listed were: health policy and 
systems research (HPSR) to improve 
Table 1. The Final Research Priority Scores and Ranks of 63 Research Options after Application of CHNRI Methodology to Address the 
Burden of Child Mortality in the Present South African Context
RPS (×100) Ranka Cause of Death Domainb Research Option
88.6 1 (1) Malnutrition 1 HPSR to achieve increased vitamin A supplementation coverage
87.8 2 (3) Diarrhoea 1 HPSR to increase hand-washing with soap
87.7 3 (3) Pneumonia 1 HPSR to achieve increased usage of antibiotic treatment for pneumonia
87.7 4 (2) HIV/AIDS 1 HPSR to increase coverage of PMTCT interventions
84.2 5 (5) Diarrhoea 1 HPSR and education/behaviour modiﬁ  cation research to increase exclusive breast-feeding 
during ﬁ  rst 6 mo
83.5 6 (6) Pneumonia 1 HPSR to improve existing ways of training health care workers to deliver pneumonia standard 
case management
83.3 7 (7) Diarrhoea 1 HPSR to increase awareness of indications for treatment and access to oral rehydration 
sachets at all times and sites
83.0 8 (8) Malnutrition 1 HPSR to improve management of severe malnutrition
82.4 9 (9) Malnutrition 1 HPSR to achieve increased zinc supplementation coverage
80.3 10 (10) Diarrhoea 2 Research to reduce costs/improve deliverability and sustainability of piped safe water 
systems
79.1 11 (11) Accidents and injuries 3 Develop affordable spill-proof parafﬁ  n stoves that comply with safety standards
77.6 12 (12) Diarrhoea 2 Research to develop sewage treatment systems affordable to developing countries
75.6 13 (13) Pneumonia 1 HPSR to increase zinc supplementation coverage
74.3 14 (15) HIV/AIDS 1 HPSR to increase access to antiretroviral treatments
73.9 15 (14) Neonatal 3 Development and testing of low-cost, robust, simple foetal heart monitors
73.7 16 (16) Malnutrition 3 Evaluating cost-effectiveness of different strategies to increase adherence of iron 
supplementation in pregnancy
72.8 17 (19) Neonatal 3 Developing the optimal strategies of implementation of post-discharge kangaroo mother 
care
72.6 18 (17) Malnutrition 2 Evaluating cost-effectiveness of cash transfer programs to improve diet quality and nutrition 
in poor areas
71.6 19 (20) Malnutrition 3 Developing new low-cost appropriate complementary foods
71.1 20 (18) HIV/AIDS 1 Behavioural research to reduce HIV risky behaviours
52.6 54 (54) Accidents and injuries 3 Developing innovative solutions to protect pedestrians
52.4 55 (57) Neonatal 2 Adapting head cooling/body cooling to be feasible/lower cost for low-resource settings
52.3 56 (55) Congenital/genetic 3 Developing cost-effective diagnostic tool for detecting congenital heart disease after birth in 
a community setting
52.0 57 (60) Neonatal 1 HPSR to achieve increased child birth-spacing intervals
51.9 58 (53) Congenital/genetic 3 Developing cost-effective diagnostic tool for early detection of congenital anomalies during 
pregnancy in a community setting
49.7 59 (60) Pneumonia 2 Research to reduce the costs of oxygen therapy and make it more available to the general 
public
49.6 60 (57) Congenital/genetic 3 Making catheter interventions for congenital heart disease more affordable
49.3 61 (59) Congenital/genetic 2 Making community genetic screening tests more affordable and cost-effective
45.6 62 (62) Neonatal 2 Adapting the procedure of amniotic infusion to lower-resource settings
30.8 63 (63) Congenital/genetic 1 HPSR to increase the coverage of screening for genetic conditions in the population 
(community genetics)
The top 20 and bottom ten research options are listed. 
aRanks in parentheses indicate RPSs before weighting by the LRG.
bDomains: 1, HPSR options to improve efﬁ  ciency of existing health systems; 2, research options to improve existing interventions; 3, research options to develop entirely new health 
interventions (see Box 1).
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efﬁ  ciency of current health care 
systems; research on improvements 
to existing interventions in terms of 
affordability and deliverability, and 
development of new interventions. 
Experts on each of the seven causes of 
death within South Africa were asked 
to select, for each of these health 
research domains, three research 
options that would, in their opinion, 
stand the best chance of being 
considered a research investment 
priority when evaluated against the 
research options addressing other 
causes of death. These experts had 
the opportunity to promote the 
same number of research options 
regardless of their relative share in 
disease burden, which made research 
options related to minor components 
of disease burden more likely to be 
over-represented rather than under-
represented on the list. 
The next step was the scoring of all 
research options by the six technical 
experts independently. Each of the 
63 research options were assessed 
with regard to five criteria: likelihood 
that the question can be answered 
using ethical methods; efficacy 
and effectiveness; deliverability, 
affordability, and sustainability; 
maximum potential to reduce the 
existing child mortality burden; 
and predicted effect on equity in 
the population. Assessment was 
made by experts’ answering three 
questions (see Box 2 for a list of the 
questions) per criterion according to 
the conceptual framework of Rudan 
et al. [5,11]. This process yielded 
five intermediate scores, all ranging 
between 0% and 100%. The exact 
methods of computing intermediate 
scores are explained elsewhere 
[5,11].
Activities of the larger reference 
group. To ensure that the assessment 
of the research priorities is combined 
with a view of the wider society, 
the relative weights for each 
criterion were measured from 30 
stakeholders’ representatives from 
the larger reference group (LRG). 
LRG members included academics 
from three Cape Town universities, 
members of the public, government 
representatives, clinical psychologists, 
and other professionals. In choosing 
LRGs, we used a convenience sample 
attempting to secure a diverse mix of 
researchers, clinicians, professionals, 
academics, and members of the public 
and allowed them to express their 
opinions through an interview and as a 
quantitative score. 
LRG members were ﬁ  rst told the 
elements of the process, then asked 
for feedback, and eventually asked 
to rank those ﬁ  ve criteria from the 
most important within the South 
African context (rank 1) to the least 
important (rank 5). The criterion of 
equity received the highest average 
rank (2.31), followed by efﬁ  cacy and 
effectiveness (2.75); deliverability, 
affordability, and sustainability (2.94); 
maximum potential for mortality 
burden reduction (3.28); and 
answerability (3.72). These observed 
average ranks were then turned into 
weights by dividing the expected 
average rank in the situation of equal 
importance of all ﬁ  ve criteria (which 
is 3.00) by the observed average rank. 
This simple procedure gives weights 
for the intermediate scores. Weighted 
means of intermediate scores were then 
computed to derive the ﬁ  nal “research 
priority score” (RPS) for each research 
option. 
Outcomes
The ﬁ  nal results of the scoring process 
of the technical experts (top 20 and 
bottom 10) are shown in Table 1. In this 
table, the scored research options are 
ranked by their ﬁ  nal RPS multiplied by 
100, which gives a range of score values 
between 0 and 100. This score takes 
into account the scores from technical 
experts, based on ﬁ  ve criteria relevant to 
priority setting, and the weights deﬁ  ned 
by the LRG. The ranks in parenthesis 
indicate RPSs before weighting by the 
LRG. The ﬁ  nal RPSs for the 63 research 
options ranged from 88.6 to 45.6, with 
the lowest score of 30.8 being an outlier. 
This range shows substantial variation 
between the research options in their 
likelihood to address the ﬁ  ve criteria, 
as assessed by the TWG and LRG, and 
1. GATHERING OF TECHNICAL EXPERTS 
AND DEFINITION OF CONTEXTS
•  Initiation of the process of priority 
setting (a governmental department, 
a nongovernmental organization, or a 
research institution) and gathering of a 
group of technical experts
• Creation  of  deﬁ  nitions for geographic 
scale (global or national), time 
period (e.g., 5 or 10 years), target 
population (child health in our case), 
and targeted disease burden (e.g., 
pneumonia, HIV)
2. LISTING RESEARCH OPTIONS 
SYSTEMATICALLY BY DOMAIN OF 
HEALTH RESEARCH
The three domains of health research are:
•  Health policy and systems research 
options (to improve efﬁ  ciency of 
health systems already in place)
•  Research options to improve existing 
interventions (affordability and 
deliverability)
•  Research options to develop entirely 
new health interventions
3. SCORING OF ALL LISTED RESEARCH 
OPTIONS BY CRITERION
Experts in the TWG score the listed 
research options against ﬁ  ve criteria:
•  Likelihood that question can be 
answered in an ethical manner
• Likelihood  of  efﬁ  cacy and effectiveness
•  Likelihood of deliverability and 
affordability
•  Maximum potential for disease burden 
reduction
•  Likely impact of equity in population
4. ADDRESSING STAKEHOLDERS’ 
VALUES
The LRG deﬁ  nes weights, which are 
placed on the ﬁ  ve scores. The ﬁ  nal RPS 
(0%–100%) is computed as weighted 
mean of intermediate scores
5. PROGRAMME BUDGETING AND 
MARGINAL ANALYSIS; ADVOCACY
•  For each research option, its “value” in 
terms of the ﬁ  ve criteria is combined 
with its proposed cost (in US$); 
program budgeting and marginal 
analysis derives optimal mix of options 
to be funded
•  Based on this selection, the TWG 
advocates making the priorities 
and rationales accessible to the 
public; implements mechanisms for 
decision review; advocates for the 
implementation of identiﬁ  ed priorities; 
and evaluates and improves the 
process based on feedback
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indicates that the methodology has the 
power to discriminate among many 
competing research options using a 
simple conceptual framework with 15 
questions.
Among the ten research options 
that received the highest RPSs (80.3 
or greater), nine of them address 
“domain 1” of health research—
HPSR for improving efﬁ  ciency with 
the interventions that are already 
in place. Four among the top ten 
options addressed diarrhoea, three 
addressed malnutrition, two addressed 
pneumonia, and one addressed 
HIV/AIDS. The priority was generally 
given to the research on more 
efﬁ  cient delivery of already existing, 
cost-effective interventions: vitamin 
A supplementation, hand washing, 
antibiotics for pneumonia, PMTCT, 
and breast-feeding. 
Among the addressed diseases and 
conditions, the most represented in 
the top were those that contribute 
most to the child mortality in South 
Africa. An exception to this rule was 
a relative under-representation of 
research options, with the exception 
of increasing PMTCT coverage, 
addressing the management of HIV/
AIDS. Research options addressing 
neonatal causes of death were also 
under-represented relative to their 
share in child mortality burden in 
South Africa.
This group of priorities is followed 
by research on improving interventions 
that could become highly efﬁ  cient if 
they could be made more affordable, 
deliverable, and sustainable, such as 
antiretroviral treatment for HIV/AIDS, 
or piped safe water systems and sewage 
treatment systems to help prevent 
diarrhoea. Another large group of 
priorities includes those addressing 
diseases and conditions with a large 
effect on mortality, but for which there 
are no existing interventions that could 
achieve high population coverage in 
an equitable way. Examples of such 
priorities are the development and 
testing of low-cost, robust, simple foetal 
heart monitors and developing the 
optimal strategies of implementation of 
post-discharge “kangaroo mother care” 
(skin-to-skin contact between mother 
and infant). In such cases, an attempt 
to develop entirely new interventions 
was given greater priority than research 
on creative scaling up or improving the 
existing interventions. 
CRITERION 1: ANSWERABILITY AND 
ETHICS
Q.1.1. Would you say the research 
question is well framed and end points 
are well deﬁ  ned? 
Q.1.2. Based on (i) the level of existing 
research capacity in proposed research, 
and (ii) the size of the gap from current 
level of knowledge to the proposed 
endpoints, would you say that a study 
can be designed to answer the research 
question and to reach the proposed end 
points of the research? 
Q.1.3. Is it likely that a study designed to 
answer the proposed research question 
would be granted ethical approval? 
CRITERION 2: EFFICACY AND 
EFFECTIVENESS
Q.2.1. Based on the best existing 
evidence and knowledge, would the 
intervention that would be developed/
improved through proposed research be 
efﬁ  cacious? 
Q.2.2. Based on the best existing 
evidence and knowledge, would the 
intervention that would be developed/
improved through proposed research be 
effective? 
Q.2.3. If the answers to either of the 
previous two questions are positive, 
would you say that the evidence upon 
which these opinions are based is of high 
quality? 
CRITERION 3: DELIVERABILITY, 
AFORDABILITY, AND SUSTAINABILITY
Q.3.1. Taking into account the level of 
difﬁ  culty with intervention delivery 
from the perspective of the intervention 
itself (e.g., design, standardisability, 
safety), the infrastructure required 
(e.g., human resources, health facilities, 
communications, and transport 
infrastructure) and users of the 
intervention (e.g., need for change of 
attitudes or beliefs, supervision, existing 
demand), would you say that the end 
points of the research would be easily 
deliverable within the context of interest? 
Q.3.2. Taking into account the resources 
available to implement the intervention, 
would you say that the end points of 
the research would be easily affordable 
within the context of interest? 
Q.3.3. Taking into account government 
capacity and partnership requirements 
(e.g., adequacy of government 
regulation, monitoring, and enforcement; 
governmental intersectoral coordination; 
partnership with civil society and external 
donor agencies; favourable political 
climate to achieve high coverage), 
would you say that the end points of 
the research would be easily sustainable 
within the context of interest? 
CRITERION 4: MAXIMUM POTENTIAL 
FOR DISEASE BURDEN REDUCTION
Q.4.1. Taking into account the results 
of conducted intervention trials 
(percentage reduction of disease 
burden in the intervention group in 
comparison to the control group) or for 
the new interventions, the proportion 
of avertable burden under an ideal 
scenario (computed from the knowledge 
of prevalence of risk factors targeted by 
future intervention and their relative 
risks, as “potential impact fraction”), 
would you say that the successful 
attainment of research end points would 
have a capacity to remove more than 
10% of disease burden?  
Q.4.2. More than 20% (or modify as 
appropriate per disease/condition)? 
Q.4.3. More than 40% (or modify as 
appropriate per disease/condition)? 
CRITERION 5: EQUITY IN ACHIEVED 
DISEASE BURDEN REDUCTION
Q.5.1. Would you say that the present 
distribution of the disease burden 
affects mainly, or almost entirely, the 
underprivileged in the population? 
Q.5.2. Would you say that mainly 
the underprivileged, or at least all 
segments of society equally, would 
be the most likely to beneﬁ  t from the 
results of the proposed research after its 
implementation, rather than primarily the 
privileged? 
Q.5.3. Would you say that the proposed 
research has the overall potential to 
improve equity in disease burden 
distribution in the long term (e.g., 10 years)? 
Box 2. Questions That Technical Experts Apply to Listed Research 
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Among the 21 research options from 
the bottom third of the ﬁ  nal list of 
rankings that involved all 63 research 
options, seven addressed congenital 
and genetic causes of child deaths, 
while another four addressed accidents 
and injuries. This low prioritization is 
not surprising, given their relatively 
low burden of disease and lack of 
cost-effective interventions. However, 
eight research options addressed 
pneumonia and neonatal conditions 
in this section, both of which cause 
signiﬁ  cant mortality. The concerns over 
the proposed research to develop new 
interventions to address pneumonia 
were answerability, affordability, and 
impact on equity. The research options 
of very low RPS addressing neonatal 
causes of deaths were focused on more 
efﬁ  cient delivery and improvement of 
existing interventions. Those scores 
reﬂ  ect very low conﬁ  dence of the 
technical experts in the potential value 
of health interventions that already 
exist to address neonatal causes of 
death.
Discussion
The results of this prioritization 
exercise suggest that child health 
research funding in South Africa 
should concentrate on HPSR options, 
especially those related to diarrhoea, 
pneumonia, and malnutrition. Our 
results are in line with the ﬁ  ndings 
from Anthony Costello and colleagues’ 
recent priority-setting exercise with 
international experts that used the 
Delphi method [12]. The results 
probably reﬂ  ect the fact that, although 
pneumonia and diarrhoeal disease 
represent 38% of the global burden of 
disease in children, only an estimated 
0.2% of the total funding spent on 
research and development is allocated 
to these conditions [13]. Furthermore, 
a recent investigation found that 97% 
of research grants from the largest not-
for-proﬁ  t sources of funds for health 
research (the US National Institutes of 
Health and the Bill and Melinda Gates 
Foundation) were for developing new 
technologies, which could reduce child 
mortality by 22%, a reduction one-third 
of what could be achieved if existing 
technologies were fully realized [14].
Research for HIV/AIDS and 
neonatal conditions did not feature 
as highly despite being the areas of 
a signiﬁ  cant burden of disease. For 
HIV/AIDS this lower prioritization was 
due to the relative lack of cost-effective 
interventions to ﬁ  ght paediatric AIDS 
that could realistically achieve high 
population coverage, such as a long-
awaited vaccine. However, a research 
option “development of HIV vaccine” 
was ranked 37th by technical experts 
and 39th after adjustments of the 
scores according to the values of 
stakeholders, because its answerability 
and effect on equity upon its initial 
implementation achieved very low 
scores in comparison to already 
existing cost-effective interventions 
available for other diseases. Neonatal 
conditions also were given lower value 
due to the lack of existing cost-effective 
interventions. This lack also explains 
why the most highly ranked research 
options addressing neonatal causes 
of death, at ranks 15 and 17, were 
those addressing the development of 
entirely new interventions, in this case 
“development and testing of low-cost, 
robust, simple foetal heart monitors” 
and “developing the optimal strategies 
of implementation of post-discharge 
kangaroo mother care”, respectively.
A recent systematic review of 
national health priorities for child 
health research in sub-Saharan 
Africa concluded that there are few 
systematically developed national 
research priorities [15]. The review also 
found that in the rare cases in which 
a country does have such priorities, 
children’s interests may be distorted by 
processes that combine all age groups 
[15]. There are no data of which we are 
aware that detail how research funding 
on child health is spent in South 
Africa. Our discussions with child 
health researchers suggest that the vast 
majority of funding is directed toward 
research addressing HIV/AIDS, and 
with substantial amounts being directed 
toward HIV vaccine research. 
Limitations of Our Approach
We do not believe the predominance of 
HPSR is due to a bias of methodology. 
In the context of the high remaining 
burden of child mortality in South 
Africa [8] and the presence of cost-
effective interventions and sufﬁ  cient 
available resources to implement them, 
we expected that the methodology 
should highlight the issues of improved 
delivery and increased coverage of 
those interventions as an immediate 
priority. Furthermore, among the 16 
research options at the bottom of the 
list of rankings, four of them (25%) 
are HPSR options (including the 
outlier at the bottom). The results 
may still be biased by the choice 
of the technical experts and LRG. 
However, even if there were such a 
bias, the methodology transparently 
presents the input from every expert 
on every criterion, so the input would 
be reviewed and challenged by other 
experts, and the feedback loop within 
the methodology would take those 
changes into account. This process of 
review also helps to identify the points 
of widespread agreement and the 
points of controversy, thereby directing 
and focusing the discussion on research 
prioritization on the key issues.
The selection of research topics was 
restricted to the top seven causes of 
death in children under age 5 in South 
Africa, which were jointly responsible 
for more than 90% of annual deaths 
in this age group [8]. Furthermore, 
for each selected cause of death, an 
equal number of research options 
addressing three domains of health 
research was proposed for scoring, to 
avoid favouring any of the domains. 
This structure led to a total of 63 
research options to score (3 options 
× 3 domains × 7 causes), which was 
feasible because all technical experts 
managed to complete the scoring 
process within 1–3 days. The time they 
initially invested into selecting those 
options ensured that the ﬁ  nal list with 
63 options did not try to present all 
theoretical research possibilities, rather 
the options that they felt were most 
likely to be identiﬁ  ed as priorities when 
evaluated against all the other options 
using the same structured process and 
a set of criteria. Finally, even though 
the methodology takes into account the 
general values of an LRG it would be 
useful to have additional criteria that 
take into account existing government 
priorities [16]. 
The challenge of this exercise was 
then to avert child mortality burden 
as quickly as possible through better 
investments in health research. 
Therefore, our exercise does not 
consider prioritization of investments 
in health care, which is perhaps even 
more important, but also an order 
of magnitude more complex. We 
acknowledge that there is also an 
important avenue of research that lies 
on the border between health research 
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and planning that should be 
considered. We clearly need research 
to identify coherent approaches to 
strengthen health systems. Operational 
research does compete with other 
national and global research priorities 
in terms of funding and, perhaps more 
importantly, in terms of technical 
expertise. Neither local communities 
nor subnational health departments in 
South Africa presently have the capacity 
to perform many of these research 
activities, and, unless more national 
and global support is provided, local 
operational research will continue to 
be ignored. Deﬁ  ning research priorities 
globally within the HPSR domain 
needs a careful and well-planned effort 
coordinated by leading experts, and 
we felt it was beyond the scope of this 
particular study, which piloted the 
methodology at the national level. 
Conclusion
The main advantages of the CHNRI 
methodology presented in this article 
over the alternative approaches 
can be summarized as: (1) being 
systematic in listing and scoring 
competing research options, thus 
limiting the inﬂ  uence of personal 
biases on the outcome; (2) being 
transparent in regard to the input and 
contribution of everyone involved in 
deciding the research priorities; (3) 
preventing one or a few individuals 
from dominating the process; (4) 
presenting a simple quantitative 
outcome (RPS); (5) simultaneously 
evaluating different domains of health 
research using the same set of criteria; 
and (6) incorporating the opinion of 
stakeholders and wider public. The 
methodology proved to be a feasible 
and transparent approach toward 
setting priorities in child health 
research investments in South Africa.
Still, the methodology is new and 
further possibilities of improvement 
are certainly possible. Some of them 
include: (1) improving strategies 
to ensure better representativeness 
of the experts who undertake the 
scoring process and stakeholders who 
introduce weights to intermediate 
scores; (2) evaluating the outcome of 
the methodology by comparing it to the 
results of other methods; (3) validating 
the results of different priority-setting 
methods by showing that they indeed 
affect disease burden and reduce it in 
an equitable way; (4) presenting the 
outcomes of the process by publication, 
by inviting comments from the wider 
research community, and by using the 
feedback loop to modify the outcomes 
based on justiﬁ  ed comments.
Our intention is to now use the 
derived scores for the ﬁ  nal steps 
shown in Box 1 to perform program 
budgeting and marginal analysis at 
the national level. Marginal analysis 
allocates available funding resources 
to identiﬁ  ed priorities to maximize 
the beneﬁ  ts. This process results in 
maximally equitable reduction of 
disease burden by choosing the optimal 
“mix” of funded research options 
within the budgetary constraint. 
We also intend to make the results 
accessible to the wider public, to 
implement mechanisms for reviewing 
the scores and decisions, to advocate 
and implement the identiﬁ  ed priorities, 
and to evaluate and improve this 
process based on feedback.  
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